TotalSeq™-B0409 抗人 CD85g (ILT7

TotalSeq™-B0409 anti-human CD85g (ILT7) Antibody详细如下：

Description ：ILT7 (immunoglobulin-like transcript 7) is a member of leukocyte immunoglobulin-like receptor(LIR or LILR) gene family, also known as CD85g and LILRA4. It contains four extracellular Igdomains. In association with FcεR1γ, ILT7 forms a receptor complex that transduces ITAMmediated signals. ILT7 is specifically expressed on plasmacytoid dendritic cells (pDCs), but noton myeloid dendritic cells and other peripheral blood leukocytes. ILT7 negatively regulates theinnate immune functions of human pDCs. Cross-linking 17G10.2 antibody is able to triggerILT7 mediated signaling.

Verified Reactivity ：Human

Antibody Type ：Monoclonal

Host Species ：Mouse

Formulation ：Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and 1 mM EDTA

Preparation ：The antibody was purified by chromatography and conjugated with TotalSeq™-B oligomer underoptimal conditions.

Concentration ：0.5 mg/mL

Storage & Handling ：The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.

Application ：PG - Quality tested

Recommended Usage ：Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometricanalysis and the oligomer sequence is confirmed by sequencing. TotalSeq™-B antibodies arecompatible with 10x Genomics Single Cell Gene Expression Solutions.

To maximize performance, it is strongly recommended that the reagent be titrated for eachapplication, and that you centrifuge the antibody dilution before adding to the cells at 14,000xg at 2- 8°C for 10 minutes. Carefully pipette out the liquid avoiding the bottom of the tube and add to thecell suspension. For Proteogenomics analysis, the suggested starting amount of this reagent fortitration is ≤ 1.0 µg per million cells in 100 µL volume. Refer to the corresponding TotalSeq™protocol for specific staining instructions.